GenScript

Executive Summary

GenScript is a globally recognized life science research services company, specializing in gene synthesis, molecular biology, and custom antibody development. Founded in 2002 and headquartered in Piscataway, New Jersey, it serves as a critical enabler for academic, pharmaceutical, and biotech research, offering foundational tools that accelerate scientific discovery and therapeutic development. With a comprehensive portfolio, GenScript supports the entire drug development pipeline, from target discovery to clinical manufacturing. The company's strong reputation and extensive customer base position it well to benefit from the growing demand for outsourced research services and the expansion of synthetic biology, cell and gene therapy, and antibody-based therapeutics. Despite facing competition from other CROs, GenScript's proven track record and technological expertise provide a competitive edge, making it a key player in the life sciences ecosystem.

Upcoming Catalysts (preview)

• Q3 2026Expansion of cell and gene therapy manufacturing services80% success
• Q2 2026Major partnership agreement with a top-tier biopharma company70% success
• Q4 2026Launch of next-generation gene synthesis platform with improved accuracy and speed60% success